PubRank

Clair Beard

Author PubWeight™ 23.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw 2009 2.40
2 NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw 2009 1.86
3 Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 2013 1.81
4 Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst 2010 1.76
5 Testicular cancer. J Natl Compr Canc Netw 2012 1.11
6 Kidney cancer. J Natl Compr Canc Netw 2011 1.06
7 Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer. J Clin Oncol 2011 0.99
8 Kidney cancer, version 2.2014. J Natl Compr Canc Netw 2014 0.98
9 Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003 0.97
10 Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology 2003 0.95
11 Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 2004 0.92
12 Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. J Urol 2007 0.89
13 Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. Int J Radiat Oncol Biol Phys 2002 0.87
14 Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw 2015 0.86
15 Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer. Urol Oncol 2006 0.83
16 Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology 2005 0.83
17 A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology 2006 0.82
18 Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. Urol Oncol 2007 0.82
19 Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol Oncol 2004 0.81
20 Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy. Urol Oncol 2005 0.80
21 Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap. J Clin Oncol 2009 0.77
22 Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization. Int J Radiat Oncol Biol Phys 2005 0.75
23 Stochastic triangulation for prostate positioning during radiotherapy using short CBCT arcs. Radiother Oncol 2013 0.75
24 Mapping patterns of nodal metastases in seminoma: rethinking radiotherapy fields. Radiother Oncol 2013 0.75